Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist

被引:23
作者
Feng, DQD [1 ]
Biftu, T
Candelore, MR
Cascieri, MA
Colwell, LF
Deng, LP
Feeney, WP
Forrest, MJ
Hom, GJ
MacIntyre, DE
Miller, RR
Stearns, RA
Strader, CD
Tota, L
Wyvratt, MJ
Fisher, MH
Weber, AE
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Physiol & Biochem, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA
[5] Merck Res Labs, Dept Comparat Med, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(00)00267-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
5-n-Pentyl oxadiazole substituted benzenesulfonamide 8 is a potent and selective beta(3) adrenergic receptor agonist (beta(3) EC50 = 23 nM, beta(1) IC50 = 3000 nM, beta(2) IC50 = 3000 nM). The compound has high oral bioavailability in dogs (62%) and rats (36%) and is among the: most orally bioavailable beta(3) adrenergic receptor agonists reported to date. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1427 / 1429
页数:3
相关论文
共 17 条
  • [1] *ACS, 1999, 217 NAT M AM CHEM SO
  • [2] Arch JRS, 1996, INT J OBESITY, V20, P191
  • [3] BETA(3)-ADRENOCEPTOR AND ATYPICAL BETA-ADRENOCEPTOR
    ARCH, JRS
    KAUMANN, AJ
    [J]. MEDICINAL RESEARCH REVIEWS, 1993, 13 (06) : 663 - 729
  • [4] CLAUS TH, 1995, ANNU REP MED CHEM, V30, P189
  • [5] A selective human β3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys
    Fisher, MH
    Amend, AM
    Bach, TJ
    Barker, JM
    Brady, EJ
    Candelore, MR
    Carroll, D
    Cascieri, MA
    Chiu, SHL
    Deng, LP
    Forrest, MJ
    Hegarty-Friscino, B
    Guan, XM
    Hom, GJ
    Hutchins, JE
    Kelly, LJ
    Mathvink, RJ
    Metzger, JM
    Miller, RR
    Ok, HO
    Parmee, ER
    Saperstein, R
    Strader, CD
    Stearns, RA
    Thompson, GM
    Tota, L
    Vicario, PP
    Weber, AE
    Woods, JW
    Wyvratt, MJ
    Zafian, PT
    MacIntyre, DE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) : 2387 - 2393
  • [6] GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964
  • [7] Himms-Hagen J., 1996, CURR OPIN ENDOCRINOL, V3, P59
  • [8] Howe Ralph, 1993, Drugs of the Future, V18, P529
  • [9] An improved oxadiazole synthesis using peptide coupling reagents
    Liang, GB
    Feng, DD
    [J]. TETRAHEDRON LETTERS, 1996, 37 (37) : 6627 - 6630
  • [10] Lowell BB, 1997, ANNU REV MED, V48, P307